Lifestyle modifications, including yoga, hypnosis, and nutraceuticals, are increasingly used in BPH management, reflecting a trend towards integrating alternative medicine with traditional treatments.

68Gallium PSMA-11 PET is preferred for confirming lutetium therapy eligibility due to its high specificity in detecting PSMA expression. Alternatives include 18F-DCFPyL PET, which also targets PSMA, ...

The NRG-GU011 trial investigates relugolix plus SBRT versus SBRT alone in PET-oligometastatic prostate cancer. ORIOLE and STOMP studies indicate SBRT can delay recurrence without early ADT in some ...

CMS will separately reimburse diagnostic radiopharmaceuticals exceeding $630 per day, enhancing access to advanced nuclear medicine scans. The new policy, effective January 1, 2025, provides stable ...

Barrigel rectal spacer aims to protect the rectum during radiation therapy for prostate cancer, with FDA clearance for T1-T3b cases. The PPRT trial is the first to include patients with recurrent ...